Ingrezza Sprinkle — Medical Mutual
Tardive Dyskinesia (TD) - Initial Therapy
Initial criteria
- Patient is age ≥ 18 years; AND
- Ingrezza is prescribed by or in consultation with a neurologist or psychiatrist; AND
- Patient has been clinically diagnosed with TD according to DSM V criteria (involuntary athetoid or choreiform movements; AND history of treatment with a neuroleptic agent; AND symptoms lasting longer than 4-8 weeks)
Approval duration
1 year